FDA accepts approval application for lurasidone Study finds Vimpat 'significantly' reduces partial-onset seizures Abbott to boost business with Facet acquisition Decision Resources: Acute migraine therapy designed for vascular disease patients will capture market share FDA committee recommends approval for InterMune’s Esbriet Clinical study: Pfizer-Bristol anticoagulant more effective than competitior Genzyme, PTC: Mid-stage trial for DBMD treatment yields mixed results Roche, Biogen Idec halt ocrelizumab trials Bristol-Myers Squibb, Isis announce partnership for cholesterol drug SXC Health Solutions signs PBM contract with HealthSpring First Previous 207 208 209 210 211 Next Last
